Parkinson’s Disease Research Studies and Clinical Trials
There are several ongoing research opportunities. For information, please contact Denyse Turpin, RN, MPH, at (617) 638-7736. Institutional Review Board approval has been obtained to publicize these trials.
- Study on Inhalable Parkinson’s Disease Medication
- Parkinson’s Progression Markers Initiative Study
- Exercise Study for People with Parkinson’s Disease
- Participants Needed for Study on the Health of Caregivers to Relatives with Parkinson’s Disease and Other Movement Disorders
- Effects of Parkinson’s Disease on Perception, Cognition and Gait
- Parkinson’s Research Study of Motor Fluctuations
- Unveiling the Natural History of Quality of Life and Mobility Changes in People with Parkinson’s Disease
- Speech and Swallowing Function in Parkinson’s Disease
- Study to Promote Walking in People with Parkinson’s Disease - Enrollment Complete
- Study of Safinamide in Early Parkinson’s Disease as Add-on to Dopamine Agonist (MOTION) - Enrollment Complete
- Safinamide as an Add-on to Levodopa in Advanced Parkinson’s Disease (SETTLE) - Enrollment Complete
- STEADY PD (Safety, Tolerability, and Efficacy Assessment of Dynacirc® CR for PD) - Enrollment Complete
- Coenzyme Q10 Research Study for Parkinson’s Disease Patients - Enrollment Complete
- Inosine Research Study in Parkinson’s Disease - Enrollment Complete
- Research Study Evaluating an Individual’s Risk of Developing Parkinson’s Disease (PARS) - Enrollment Complete
